eXoZymes, Inc. cash flow to debt ratio of -522.99% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

eXoZymes, Inc.'s free cash flow has increased -25.05% from $-8.90M last year to $-6.67M, signaling increasing performance

eXoZymes, Inc.'s debt to equity ratio is 0.76, which means that the company's assets are unhealthy financed, signaling financial risk.

eXoZymes, Inc.'s debt has increased relative to shareholder equity from 0.13 last year to 0.76 today, signaling weakened financials

eXoZymes, Inc. has a net cash position, so leverage is healthy.

Interest expense is not separately reported in eXoZymes, Inc.'s latest filing, so interest coverage cannot be calculated.

eXoZymes, Inc. has insufficient data to evaluate this check.

eXoZymes, Inc.'s short-term assets of $3.94M exceed its short-term liabilities of $1.57M

eXoZymes, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

eXoZymes, Inc.'s return on equity of -220.64%, is lower than 15.00%, indicating bad performance

eXoZymes, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

eXoZymes, Inc. has insufficient public price history to evaluate earnings stability.

eXoZymes, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

eXoZymes, Inc. has negative free cash flow, indicating cash burn

eXoZymes, Inc.'s yearly earnings has decreased 56.26% since last year from $-5.86M to $-9.16M, signaling decreasing performance

eXoZymes, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -362.40% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

eXoZymes, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

eXoZymes, Inc. has insufficient public price history to evaluate revenue consistency.

eXoZymes, Inc. has insufficient public price history to evaluate ROE consistency.

eXoZymes, Inc. has insufficient data to evaluate this check.

eXoZymes, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

eXoZymes, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

eXoZymes, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

eXoZymes, Inc. has insufficient data to evaluate this check.

eXoZymes, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

eXoZymes, Inc. has a price-to-book ratio of 28.78x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

eXoZymes, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue